TITLE

Sudden loss of vision: Purtscher retinopathy in multiple myeloma

AUTHOR(S)
Nautiyal, Amit; Amescua, Guillermo; Jameson, Angus; Gradowski, Joel F.; Feiyu Hong; Doft, Bernard
PUB. DATE
December 2009
SOURCE
CMAJ: Canadian Medical Association Journal;12/8/2009, Vol. 181 Issue 12, pE277
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the prognosis of Purtscher retinopathy which causes sudden loss of vision. It mentions that the said disease has caused the 53 year old woman loss her vision. A bone marrow biopsy was performed on the patient that showed her plasma cells inflicted with multiple myeloma. It stresses that hyperviscosity from multiple myeloma has played a role in the patient's visual loss.
ACCESSION #
47036418

 

Related Articles

  • Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma. Štifter, Sanja; Babarovic, Emina; Valkovic, Toni; Seili-Bekafigo, Irena; Štemberger, Christophe; Nacinovic, Antica; Lucin, Ksenija; Jonjic, Nives // Diagnostic Pathology;2010, Vol. 5, p30 

    Background: Estimation of plasma cell infiltrates in bone marrow aspirates (BMA) and bone marrow biopsy (BMB) is a standard method in the diagnosis and monitoring of multiple myeloma (MM). Plasma cell fraction in the bone marrow is therefore critical for the classification and optimal clinical...

  • Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma. Waizenegger, J S; Ben-Batalla, I; Weinhold, N; Meissner, T; Wroblewski, M; Janning, M; Riecken, K; Binder, M; Atanackovic, D; Taipaleenmaeki, H; Schewe, D; Sawall, S; Gensch, V; Cubas-Cordova, M; Seckinger, A; Fiedler, W; Hesse, E; Kröger, N; Fehse, B; Hose, D // Leukemia (08876924);Mar2015, Vol. 29 Issue 3, p696 

    Multiple myeloma is a mostly incurable malignancy characterized by the expansion of a malignant plasma cell (PC) clone in the human bone marrow (BM). Myeloma cells closely interact with the BM stroma, which secretes soluble factors that foster myeloma progression and therapy resistance. Growth...

  • Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature. Siragusa, Sergio; Morice, William; Gertz, Morie A.; Kyle, Robert A.; Greipp, Philip R.; Lust, John A.; Witzig, Thomas E.; Lacy, Martha Q.; Zeldenrust, Steven R.; Rajkumar, S. Vincent; Russell, Stephen J.; Hayman, Suzanne R.; Buadi, Francis; Kumar, Shaji K.; Dingli, David; Dispenzieri, Angela // Annals of Hematology;Jan2011, Vol. 90 Issue 1, p101 

    The rate of asymptomatic amyloidosis (AL) among patients with newly diagnosed multiple myeloma (MM) or smoldering multiple myeloma (SMM) is unknown. We evaluated number and clinical significance of asymptomatic AL in consecutive MM and SMM patients, not having recognition of symptomatic AL at...

  • Clinical challenges: Myeloma and concomitant Type 2 Diabetes. Rahiem Ahmed, Yasar Albushra Abdul; Eltayeb, Awad // International Journal of Hematology-Oncology & Stem Cell Researc;Jan2013, Vol. 7 Issue 1, p31 

    Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there...

  • Progression Risk for Smoldering Myeloma. Artz, Andrew // Clinical Oncology Alert;Aug2007, Vol. 23 Issue 8, p59 

    MONOCLONAL GAMMOPATHIES ENCOMPASS A spectrum of disorders related to a clonal proliferation of plasma cells. Although not necessarily distinct entities, diagnostic criteria separate monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma. To diagnose...

  • Acquired Pure Red Cell Aplasia in patients with plasma cell neoplasm and long term remission with bortezomib therapy. Sarathy, Kiran S.; Ramakrishna, Raj; Baig, Waqas W.; Manoharan, Arumugum // Journal of Hematological Malignancies;Jun2013, Vol. 3 Issue 2, p37 

    We report two cases of Pure Red Cell Aplasia (PRCA) associated with plasma cell dyscrasia. The first case is of an elderly woman with PRCA and light chain disease (LCD)/multiple myeloma (MM). She received multiple blood transfusions and was refractory to conventional therapies. Subsequent...

  • Clinical, Immunophenotypic, and Genetic Characterization of Small Lymphocyte–Like Plasma Cell Myeloma: A Potential Mimic of Mature B-Cell Lymphoma. Amy Heerema-McKenney // American Journal of Clinical Pathology;Feb2010, Vol. 133 Issue 2, p265 

    We reviewed bone marrow studies from 351 multiple myeloma (MM) cases, selecting 12 cases (3.4%) with predominantly small lymphocyte–like morphologic features resembling B-cell lymphoma, and correlated their genetic and clinical features. All exhibited a diffuse interstitial pattern of...

  • Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs. Köse, Murat; Buraniqi, Ersida; Akpinar, Timur Selçuk; Kayacan, Seyit Mehmet; Tükek, Tufan // Case Reports in Hematology;1/28/2015, Vol. 2015, p1 

    Multiple myeloma is a neoplastic plasma cell disorder. It is characterized by collections of abnormal plasma cells accumulating in the bone marrow, where they interfere with the production of normal blood cells. It usually presents as a multisystemic involvement, whose symptoms and signs vary...

  • Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Hideshima, Teru; Mitsiades, Constantine; Tonon, Giovanni; Richardson, Paul G.; Anderson, Kenneth C. // Nature Reviews Cancer;Aug2007, Vol. 7 Issue 8, p585 

    Multiple myeloma is a plasma cell malignancy characterized by complex heterogeneous cytogenetic abnormalities. The bone marrow microenvironment promotes multiple myeloma cell growth and resistance to conventional therapies. Although multiple myeloma remains incurable, novel targeted agents, used...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics